The feasibility of withdrawing canakinumab in paediatric colchicine-resistant familial Mediterranean fever patients

Sozeri, B.; Sonmez, H.; Karadag, S.; Baglan, E.; Ozturk, K.; Cakan, M.; Demir, F.; Yener, G.; Ozdel, S.; Ayaz, N.

The feasibility of withdrawing canakinumab in paediatric colchicine-resistant familial Mediterranean fever patients

Sozeri B., Sonmez H. E., Karadag S. G., Baglan E., Ozturk K., Cakan M., ...Daha Fazla

CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, cilt.39, sa.5, 2021 (SCI-Expanded, Scopus)

Yayın Türü: Makale / Tam Makale
Cilt numarası: 39 Sayı: 5
Basım Tarihi: 2021
Dergi Adı: CLINICAL AND EXPERIMENTAL RHEUMATOLOGY
Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus, CAB Abstracts, EMBASE, MEDLINE, Veterinary Science Database
Anahtar Kelimeler: canakinumab, colchicine resistance, familial Mediterranean fever, CHILDREN
İstanbul Üniversitesi Adresli: Hayır

Özet

Objective. To determine the feasibility of withdrawing canakinumab (CAN) in a large cohort of paediatric patients with colchicine-resistant familial Mediterranean fever (crFMF).